换一批
换一批A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia.
第一作者：
Paolo,Strati
第一单位：
Department of Leukemia, The University of Texas M. D. Anderson Cancer Center , Houston, TX , USA.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);用药计划表(Drug Administration Schedule);红斑(Erythema);随访研究(Follow-Up Studies);粒细胞巨噬细胞集落刺激因子(Granulocyte-Macrophage Colony-Stimulating Factor);人类(Humans);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);中年人(Middle Aged);缓解诱导(Remission Induction);存活率分析(Survival Analysis);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.3109/10428194.2014.974049
PMID
25311497
发布时间
2021-10-21
- 浏览12
Leukemia & lymphoma
1878-80页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
